Keith A. Goldan

Insider Reports History

Location
Conshohocken, PA
Signature
/s/ Michael A. Metzger, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Keith A. Goldan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Syndax Pharmaceuticals Inc Chief Financial Officer Common Stock 140,429 $2,952,941 $21.03 09 Feb 2026 Direct
Syndax Pharmaceuticals Inc Chief Financial Officer Stock Options (Right to buy) 118,000 $2,410,740 $20.43 04 Feb 2026 Direct
OptiNose, Inc. Chief Financial Officer Common Stock 141,726 $162,985 $1.15 16 Mar 2022 Direct
OptiNose, Inc. Chief Financial Officer Stock Option (Right to Buy) 66,185 11 Jan 2022 Direct

Insider Reports Filed by Keith A. Goldan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SNDX Syndax Pharmaceuticals Inc 09 Feb 2026 1 -$71,705 4 Chief Financial Officer 10 Feb 2026, 08:59
SNDX Syndax Pharmaceuticals Inc 04 Feb 2026 5 +$2,378,146 4 Chief Financial Officer 06 Feb 2026, 17:53
SNDX Syndax Pharmaceuticals Inc 01 Dec 2025 1 $0 4 Chief Financial Officer 01 Dec 2025, 16:30
SNDX Syndax Pharmaceuticals Inc 31 Jul 2025 1 +$10,335 4 Chief Financial Officer 07 Aug 2025, 17:30
SNDX Syndax Pharmaceuticals Inc 16 Jul 2025 1 -$12,033 4 Chief Financial Officer 18 Jul 2025, 16:30
SNDX Syndax Pharmaceuticals Inc 19 May 2025 1 $0 4 Chief Financial Officer 19 May 2025, 16:04
SNDX Syndax Pharmaceuticals Inc 10 Feb 2025 1 -$58,559 4 Chief Financial Officer 12 Feb 2025, 17:16
SNDX Syndax Pharmaceuticals Inc 05 Feb 2025 3 +$1,618,825 4 Chief Financial Officer 07 Feb 2025, 16:44
SNDX Syndax Pharmaceuticals Inc 14 Jun 2024 1 +$25,037 4 Chief Financial Officer 17 Jun 2024, 09:26
SNDX Syndax Pharmaceuticals Inc 07 Feb 2024 5 +$1,595,827 4 Chief Financial Officer 09 Feb 2024, 16:05
SNDX Syndax Pharmaceuticals Inc 13 Jun 2023 1 -$12,873 4 Chief Financial Officer 14 Jun 2023, 16:20
SNDX Syndax Pharmaceuticals Inc 02 Feb 2023 1 +$3,140,500 4 Chief Financial Officer 03 Feb 2023, 16:00
SNDX Syndax Pharmaceuticals Inc 13 Jun 2022 2 +$3,588,000 4 Chief Financial Officer 15 Jun 2022, 16:12
SNDX Syndax Pharmaceuticals Inc 13 Jun 2022 0 $0 3 Chief Financial Officer 15 Jun 2022, 16:05
OPTN OptiNose, Inc. 16 Mar 2022 1 -$9,742 4 Chief Financial Officer 17 Mar 2022, 13:23
OPTN OptiNose, Inc. 11 Jan 2022 3 $0 4 Chief Financial Officer 12 Jan 2022, 15:02
OPTN OptiNose, Inc. 16 Dec 2021 1 -$951 4 Chief Financial Officer 17 Dec 2021, 08:27
OPTN OptiNose, Inc. 16 Sep 2021 1 -$1,612 4 Chief Financial Officer 17 Sep 2021, 13:53
OPTN OptiNose, Inc. 17 Jun 2021 1 -$2,148 4 Chief Financial Officer 17 Jun 2021, 18:35